Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
暂无分享,去创建一个
T. Stamey | J. McNeal | J E McNeal | M Noguchi | T A Stamey | C M Yemoto | C. Yemoto | M. Noguchi | Masanori Noguchi
[1] D. Bostwick,et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. , 1995, The Journal of urology.
[2] P. Humphrey,et al. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues , 1995 .
[3] D. Thickman,et al. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. , 1996, The Journal of urology.
[4] T. Esen,et al. Discrepancy between Gleason Scores of Biopsy and Radical Prostatectomy Specimens , 2000, European Urology.
[5] D. Bostwick,et al. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. , 1994, The American journal of surgical pathology.
[6] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[7] D. Bostwick,et al. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. , 1993, The Urologic clinics of North America.
[8] T. Stamey,et al. Assessment of morphometric measurements of prostate carcinoma volume , 2000, Cancer.
[9] W. Fair,et al. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.
[10] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[11] T. Stamey,et al. Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.
[12] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[13] A. Rademaker,et al. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen. , 1997, The Journal of urology.
[14] M. Terris,et al. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. , 1992, The Journal of urology.
[15] T. Stamey,et al. Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume. , 1995, Urology.
[16] D. Bostwick,et al. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. , 1996, The Journal of urology.
[17] T. Stamey,et al. Making the most out of six systematic sextant biopsies. , 1995, Urology.
[18] T. Stamey,et al. Effect of Ageing on Morphologic and Clinical Predictors of Prostate Cancer Progression , 2000 .